5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.17▲ | 3.16▲ | 3.18▲ | 3.25▼ | 3.74▼ |
MA10 | 3.16▲ | 3.18▲ | 3.18▲ | 3.24▼ | 4.82▼ |
MA20 | 3.17▲ | 3.18▲ | 3.22▼ | 3.65▼ | 5.83▼ |
MA50 | 3.18▲ | 3.26▼ | 3.22▼ | 4.95▼ | 7.58▼ |
MA100 | 3.22▼ | 3.25▼ | 3.47▼ | 5.87▼ | 10.17▼ |
MA200 | 3.23▼ | 3.59▼ | 4.12▼ | 6.96▼ | 18.19▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.001▲ | -0.003▼ | 0.042▲ | -0.246▼ |
RSI | 54.321▲ | 47.444▼ | 44.800▼ | 27.814▼ | 32.168▼ |
STOCH | 65.227 | 21.117 | 54.967 | 29.201 | 4.023▼ |
WILL %R | -8.333▲ | -35.294 | -35.294 | -82.328▼ | -96.279▼ |
CCI | 98.682 | -5.811 | 19.222 | -65.957 | -118.628▼ |
CDL | $RPTX Doji Candlestick Pattern Detected | Set Alert |
Friday, April 26, 2024 01:57 PM
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of ...
|
Tuesday, April 23, 2024 09:00 AM
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation ...
|
Tuesday, April 23, 2024 09:00 AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/04/24 | 3.21 | 3.215 | 3.13 | 3.185 | 71,408 |
25/04/24 | 3.26 | 3.26 | 3.1144 | 3.15 | 82,157 |
24/04/24 | 3.37 | 3.4198 | 3.26 | 3.30 | 73,015 |
23/04/24 | 3.24 | 3.43 | 3.24 | 3.36 | 175,626 |
22/04/24 | 3.16 | 3.40 | 3.09 | 3.26 | 109,321 |
19/04/24 | 3.02 | 3.28 | 2.98 | 3.15 | 219,182 |
18/04/24 | 3.19 | 3.25 | 3.00 | 3.02 | 140,289 |
17/04/24 | 3.37 | 3.37 | 3.16 | 3.21 | 79,291 |
16/04/24 | 3.47 | 3.47 | 3.24 | 3.34 | 85,215 |
15/04/24 | 3.65 | 3.71 | 3.35 | 3.47 | 89,849 |
|
|
||||
|
|
||||
|
|